David L. Porter

818 total citations
15 papers, 429 citations indexed

About

David L. Porter is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, David L. Porter has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in David L. Porter's work include CAR-T cell therapy research (6 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). David L. Porter is often cited by papers focused on CAR-T cell therapy research (6 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). David L. Porter collaborates with scholars based in United States, Australia and Slovakia. David L. Porter's co-authors include Joseph H. Antin, Bruce L. Levine, Carl H. June, Mark A. Goldberg, Stephan A. Grupp, William D. Stuart, Julio Cotte, David Liebowitz, Zhaohui Zheng and Ginna G. Laport and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Experimental Cell Research.

In The Last Decade

David L. Porter

12 papers receiving 417 citations

Peers

Countries citing papers authored by David L. Porter

Since Specialization

Citations

This map shows the geographic impact of David L. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Porter more than expected).

Fields of papers citing papers by David L. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Porter. The network helps show where David L. Porter may publish in the future.

Co-authorship network of co-authors of David L. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Porter. A scholar is included among the top collaborators of David L. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Porter. David L. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their Caregivers 2025 ·Transplantation and Cellular Therapy ·(unknown), Ryan Quinn, (unknown), Alfred L. Garfall, David L. Porter, Salimah H. Meghani, Jie Deng	0
2	Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period 2025 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pashna N. Munshi, Peter Gabriel, Alison W. Loren, David L. Porter, Emily Baumrin	0
3	Long-Term Quality of Life, Cognitive Function, and Symptom Burden Among Chimeric Antigen Receptor T-Cell Recipients and Associated Cytokine Release Syndrome and Neurotoxicity 2025 ·JCO Oncology Practice ·(unknown), Ryan Quinn, (unknown), Alfred L. Garfall, David L. Porter, Salimah H. Meghani, Jie Deng	2
4	Defining the Optimal Post-CART Monitoring Period in Recipients of Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel: A Cell Therapy Consortium Study 2024 ·Transplantation and Cellular Therapy ·(unknown), Peter A. Riedell, David L. Porter, Forat Lutfi, Veronika Bachanová, Loretta J. Nastoupil, Richard T. Maziarz, (unknown), Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Miguel‐Angel Perales, Michael Bishop, Joseph P. McGuirk, Nausheen Ahmed	1
5	Building the Future of CAR-T Therapy: Empowering Clinicians through an Outpatient Infrastructure Development Workshop 2024 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), Olalekan O. Oluwole, David L. Porter, Heather Landau, Veronika Bachanová	1
6	Frailty Phenotype Declines in Older Patients after Allogeneic Transplantation and Predicts Subsequent Overall Survival 2023 ·Transplantation and Cellular Therapy ·Shannon R. McCurdy, Shannon Gier, Saar Gill, Mary Ellen Martin, Catherine Lai, Noelle V. Frey, Elizabeth O. Hexner, Selina M. Luger, David L. Porter, Alison W. Loren, Phyllis A. Gimotty	0
7	CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration 2019 ·Journal of Clinical Investigation ·Christopher L. Nobles, Scott Sherrill-Mix, J.K. Everett, Shantan Reddy, Joseph A. Fraietta, David L. Porter, Noelle V. Frey, Saar Gill, Stephan A. Grupp, Shannon L. Maude, Donald L. Siegel, Bruce L. Levine, Carl H. June, Simon F. Lacey, J. Joseph Melenhorst, Frederic D. Bushman	87
8	Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating Stem Cell Differentiation 2007 ·Biology of Blood and Marrow Transplantation ·Elizabeth O. Hexner, (unknown), Yi Zhang, Dale Frank, James L. Riley, Bruce L. Levine, David L. Porter, Carl H. June, Stephen G. Emerson	25
9	Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation 2003 ·Blood ·Ginna G. Laport, Bruce L. Levine, Edward A. Stadtmauer, Stephen J. Schuster, Selina M. Luger, Stephan A. Grupp, Nancy Bunin, Frank J. Strobl, Julio Cotte, Zhaohui Zheng, Brian Gregson, (unknown), Robert H. Vonderheide, David Liebowitz, David L. Porter, Carl H. June	153
10	The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy 1999 ·Annual Review of Medicine ·David L. Porter, Joseph H. Antin	93
11	Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions 1997 ·Cancer treatment and research ·David L. Porter, Joseph H. Antin	11
12	Regulation of erythropoietin production. 1993 ·PubMed ·David L. Porter, Mark A. Goldberg	30
13	Analysis of heat-denatured DNA using native agarose gel electrophoresis. 1992 ·PubMed ·David L. Porter, (unknown)	3
14	Biographical Dictionary of American Sports: Basketball and Other Indoor Sports. 1991 ·Journal of American History ·John W. Bailey, David L. Porter	2
15	An improved in situ hybridization method 1978 ·Experimental Cell Research ·William D. Stuart, David L. Porter	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact